Product  	Product  	 NN	B-NP
evaluation  	evaluation  	 NN	I-NP
of  	of  	 IN	I-NP
Ureadin  	Ureadin  	 NNP	I-NP
Rx  	Rx  	 NNP	I-NP
Db  	Db  	 NNP	I-NP
( 	( 	 -LRB-	O
ISDIN 	ISDIN 	 NNP	B-NP
)  	)  	 -RRB-	O
for  	for  	 IN	O
prevention  	prevention  	 NN	O
and  	and  	 CC	O
treatment  	treatment  	 NN	O
of  	of  	 IN	O
mild-to-moderate  	mild-to-moderate  	 JJ	B-NP
xerosis  	xerosis  	 NN	I-NP
of  	of  	 IN	O
the  	the  	 DT	O
foot  	foot  	 NN	O
in  	in  	 IN	O
diabetic  	diabetic  	 JJ	B-NP
patients 	patients 	 NNS	I-NP
.  	.  	 .	O
Prevention  	Prevention  	 NN	O
of  	of  	 IN	O
skin  	skin  	 NN	O
lesions  	lesions  	 NNS	O
due  	due  	 JJ	O
to  	to  	 TO	O
microangiopathy  	microangiopathy  	 VB	O
The  	The  	 DT	O
aim  	aim  	 NN	O
of  	of  	 IN	O
this  	this  	 DT	O
pilot 	pilot 	 NN	O
,  	,  	 ,	O
registry  	registry  	 JJ	B-NP
study  	study  	 NN	I-NP
was  	was  	 VBD	O
to  	to  	 TO	O
evaluate  	evaluate  	 VB	O
a  	a  	 DT	O
dermatological  	dermatological  	 JJ	B-NP
solution  	solution  	 NN	I-NP
Ureadin  	Ureadin  	 NNP	I-NP
Rx  	Rx  	 NNP	I-NP
Db  	Db  	 NNP	I-NP
( 	( 	 -LRB-	O
ISDIN 	ISDIN 	 NNP	B-NP
)  	)  	 -RRB-	O
including  	including  	 VBG	B-NP
urea  	urea  	 NN	I-NP
in  	in  	 IN	O
a  	a  	 DT	O
water-lipid-based  	water-lipid-based  	 JJ	B-NP
foam  	foam  	 NN	I-NP
delivery  	delivery  	 NN	I-NP
system  	system  	 NN	I-NP
in  	in  	 IN	O
diabetic  	diabetic  	 JJ	B-NP
subjects  	subjects  	 NNS	I-NP
with  	with  	 IN	O
microangiopathy  	microangiopathy  	 NN	B-NP
and  	and  	 CC	O
with  	with  	 IN	O
mild-to-moderate  	mild-to-moderate  	 JJ	B-NP
xerosis  	xerosis  	 NN	I-NP
of  	of  	 IN	O
the  	the  	 DT	O
foot 	foot 	 NN	O
.  	.  	 .	O
The  	The  	 DT	O
product  	product  	 NN	O
was  	was  	 VBD	O
applied  	applied  	 VBN	O
to  	to  	 TO	O
the  	the  	 DT	O
whole  	whole  	 JJ	O
surface  	surface  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
foot  	foot  	 NN	O
and  	and  	 CC	O
particularly  	particularly  	 RB	O
on  	on  	 IN	O
the  	the  	 DT	O
affected  	affected  	 JJ	O
areas  	areas  	 NNS	O
and  	and  	 CC	O
pressure 	pressure 	 NN	B-NP
/ 	/ 	 CD	I-NP
contact  	contact  	 NN	I-NP
zones 	zones 	 NNS	I-NP
,  	,  	 ,	O
at  	at  	 IN	O
least  	least  	 JJS	O
twice  	twice  	 RB	O
daily  	daily  	 JJ	O
for  	for  	 IN	O
4  	4  	 CD	O
weeks 	weeks 	 NNS	O
.  	.  	 .	O
Skin  	Skin  	 NN	O
breaks 	breaks 	 NNS	O
,  	,  	 ,	O
ulcerations 	ulcerations 	 NN	O
,  	,  	 ,	O
infection 	infection 	 NN	B-NP
,  	,  	 ,	O
investigator  	investigator  	 NN	B-NP
and  	and  	 CC	O
patients 	patients 	 NNS	O
'  	'  	 POS	O
questionnaire 	questionnaire 	 NN	O
,  	,  	 ,	O
microcirculatory  	microcirculatory  	 JJ	B-NP
measurements 	measurements 	 NNS	I-NP
,  	,  	 ,	O
skin  	skin  	 NN	O
thickness  	thickness  	 NN	O
( 	( 	 -LRB-	O
ultrasound 	ultrasound 	 LS	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
laser  	laser  	 FW	B-NP
Doppler  	Doppler  	 FW	I-NP
flux  	flux  	 FW	I-NP
and  	and  	 CC	O
other  	other  	 JJ	O
parameters  	parameters  	 NNS	O
were  	were  	 VBD	O
observed  	observed  	 VBN	O
and  	and  	 CC	O
evaluated  	evaluated  	 VBN	O
at  	at  	 IN	O
inclusion  	inclusion  	 NN	O
and  	and  	 CC	O
4  	4  	 CD	O
weeks 	weeks 	 NNS	O
.  	.  	 .	O
The  	The  	 DT	O
evaluation  	evaluation  	 NN	O
in  	in  	 IN	O
skin  	skin  	 NN	O
breaks  	breaks  	 NNS	O
indicated  	indicated  	 VBD	O
a  	a  	 DT	O
decrease  	decrease  	 NN	O
in  	in  	 IN	O
breaks  	breaks  	 NNS	O
in  	in  	 IN	O
the  	the  	 DT	O
Ureadin  	Ureadin  	 JJ	B-NP
group  	group  	 NN	I-NP
vs  	vs  	 NN	O
controls  	controls  	 NNS	O
( 	( 	 -LRB-	O
p  	p  	 CD	O
< 	< 	 SYM	O
0.05 	0.05 	 CD	O
)  	)  	 -RRB-	O
with  	with  	 IN	O
the  	the  	 DT	O
development  	development  	 NN	O
of  	of  	 IN	O
one  	one  	 CD	O
ulcer  	ulcer  	 NN	B-NP
in  	in  	 IN	O
controls 	controls 	 NNS	O
.  	.  	 .	O
There  	There  	 EX	O
was  	was  	 VBD	O
a  	a  	 DT	O
significant  	significant  	 JJ	O
difference  	difference  	 NN	O
in  	in  	 IN	O
favour  	favour  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
Ureadin  	Ureadin  	 JJ	B-NP
group  	group  	 NN	I-NP
in  	in  	 IN	O
both  	both  	 PDT	O
the  	the  	 DT	O
Investigator  	Investigator  	 JJ	B-NP
global  	global  	 JJ	O
assessment  	assessment  	 NN	O
and  	and  	 CC	O
in  	in  	 IN	O
the  	the  	 DT	O
subjects 	subjects 	 NNS	B-NP
'  	'  	 POS	O
assessment  	assessment  	 NN	B-NP
questionanire  	questionanire  	 NNS	I-NP
( 	( 	 -LRB-	O
p  	p  	 CD	O
< 	< 	 SYM	O
0.05 	0.05 	 CD	O
) 	) 	 -RRB-	O
.  	.  	 .	O
At  	At  	 IN	O
4  	4  	 CD	O
weeks  	weeks  	 NNS	O
PO2  	PO2  	 RB	B-NP
was  	was  	 VBD	O
improved  	improved  	 VBN	O
in  	in  	 IN	O
the  	the  	 DT	O
Ureadin  	Ureadin  	 JJ	B-NP
group  	group  	 NN	I-NP
( 	( 	 -LRB-	O
p  	p  	 CD	O
< 	< 	 SYM	O
0.05 	0.05 	 CD	O
)  	)  	 -RRB-	O
and  	and  	 CC	O
PCO2  	PCO2  	 NNP	B-NP
was  	was  	 VBD	O
significantly  	significantly  	 RB	O
better  	better  	 JJR	O
( 	( 	 -LRB-	O
p  	p  	 CD	O
< 	< 	 SYM	O
0.05 	0.05 	 CD	O
)  	)  	 -RRB-	O
in  	in  	 IN	O
the  	the  	 DT	O
Ureadin  	Ureadin  	 JJ	B-NP
group 	group 	 NN	I-NP
.  	.  	 .	O
Skin  	Skin  	 NN	O
thickness  	thickness  	 NN	O
was  	was  	 VBD	O
increased  	increased  	 VBN	O
( 	( 	 -LRB-	O
p  	p  	 CD	O
< 	< 	 SYM	O
0.05 	0.05 	 CD	O
)  	)  	 -RRB-	O
in  	in  	 IN	O
the  	the  	 DT	O
Ureadin  	Ureadin  	 JJ	B-NP
group  	group  	 NN	I-NP
( 	( 	 -LRB-	O
no  	no  	 DT	O
change  	change  	 NN	O
in  	in  	 IN	O
controls 	controls 	 NNS	O
)  	)  	 -RRB-	O
indicating  	indicating  	 VBG	O
a  	a  	 DT	O
better  	better  	 JJR	O
hydration  	hydration  	 NN	B-NP
of  	of  	 IN	O
the  	the  	 DT	O
more  	more  	 RBR	O
superficial  	superficial  	 JJ	B-NP
skin  	skin  	 NN	I-NP
layers 	layers 	 NNS	I-NP
.  	.  	 .	O
Skin  	Skin  	 NN	B-NP
flux  	flux  	 NN	I-NP
and  	and  	 CC	O
the  	the  	 DT	O
venoarteriolar  	venoarteriolar  	 JJ	B-NP
response  	response  	 NN	I-NP
were  	were  	 VBD	O
better  	better  	 RB	O
improved  	improved  	 VBN	O
in  	in  	 IN	O
the  	the  	 DT	O
Ureadin  	Ureadin  	 JJ	B-NP
group 	group 	 NN	I-NP
.  	.  	 .	O
Considering  	Considering  	 VBG	O
new  	new  	 JJ	O
skin  	skin  	 NN	O
lesions  	lesions  	 NNS	O
at  	at  	 IN	O
4  	4  	 CD	O
weeks  	weeks  	 NNS	O
there  	there  	 EX	O
were  	were  	 VBD	O
no  	no  	 DT	O
Class  	Class  	 NN	O
A  	A  	 DT	O
lesions  	lesions  	 NN	O
in  	in  	 IN	O
the  	the  	 DT	O
Ureadin  	Ureadin  	 JJ	B-NP
group  	group  	 NN	I-NP
vs.  	vs.  	 IN	O
4  	4  	 CD	O
lesions  	lesions  	 NNS	O
in  	in  	 IN	O
26  	26  	 CD	O
patients  	patients  	 NNS	O
( 	( 	 -LRB-	O
15.38 	15.38 	 NNP	O
% 	% 	 NN	O
;  	;  	 :	O
p  	p  	 CD	O
< 	< 	 SYM	O
0.05 	0.05 	 CD	O
)  	)  	 -RRB-	O
in  	in  	 IN	O
the  	the  	 DT	O
control  	control  	 NN	B-NP
group 	group 	 NN	I-NP
.  	.  	 .	O
There  	There  	 EX	O
was  	was  	 VBD	O
also  	also  	 RB	O
a  	a  	 DT	O
Class  	Class  	 NNP	B-NP
B  	B  	 NNP	I-NP
lesion  	lesion  	 NNS	I-NP
( 	( 	 -LRB-	O
3.84 	3.84 	 CD	O
% 	% 	 NN	O
;  	;  	 :	O
p  	p  	 CD	O
< 	< 	 SYM	O
0.05 	0.05 	 CD	O
)  	)  	 -RRB-	O
in  	in  	 IN	O
controls 	controls 	 NNS	O
.  	.  	 .	O
Diabetic  	Diabetic  	 JJ	B-NP
control  	control  	 NN	I-NP
was  	was  	 VBD	O
good  	good  	 JJ	O
( 	( 	 -LRB-	O
as  	as  	 RB	O
before  	before  	 IN	O
inclusion  	inclusion  	 NN	O
and  	and  	 CC	O
did  	did  	 VBD	O
not  	not  	 RB	O
change  	change  	 VB	O
at  	at  	 IN	O
4  	4  	 CD	O
weeks 	weeks 	 NNS	O
) 	) 	 -RRB-	O
.  	.  	 .	O
Therefore  	Therefore  	 RB	O
the  	the  	 DT	O
clinical  	clinical  	 JJ	O
and  	and  	 CC	O
microcirculatory  	microcirculatory  	 JJ	B-NP
changes  	changes  	 NNS	I-NP
were  	were  	 VBD	O
very  	very  	 RB	O
possibly  	possibly  	 RB	O
due  	due  	 JJ	O
only  	only  	 JJ	O
to  	to  	 TO	O
local  	local  	 JJ	O
management  	management  	 NN	O
and  	and  	 CC	O
not  	not  	 RB	O
to  	to  	 TO	O
a  	a  	 DT	O
systemic  	systemic  	 JJ	B-NP
improvement  	improvement  	 NN	I-NP
in  	in  	 IN	O
the  	the  	 DT	O
management  	management  	 NN	O
of  	of  	 IN	O
diabetes 	diabetes 	 NN	O
.  	.  	 .	O
